Back

Journal of Clinical Virology Plus

○ Elsevier BV

Preprints posted in the last 90 days, ranked by how well they match Journal of Clinical Virology Plus's content profile, based on 10 papers previously published here. The average preprint has a 0.00% match score for this journal, so anything above that is already an above-average fit.

1
Community-based assessment of mpox seroprevalence and undocumented exposures in Manitoba and Alberta, Canada

Gork, E.; Hunter, M.; Battle, N.; Wilson, N.; Polege, S.; Robles, C.; Vincent, V.; Meyer, G.; Wallace, H. L.; Saxinger, L.; Bullard, J.; Halbrook, M. L.; Merritt, S.; Hoff, N. A.; Noyce, R. S.; Vinh, D. C.; Souleymanov, R.; Shaw, S. Y.; Mbala-Kingebeni, P.; Rimoin, A. W.; Meier-Stephenson, V.; Kindrachuk, J.

2026-09-20 infectious diseases 10.64898/2026.09.17.26363367 medRxiv
Top 0.1%
1.4%
Show abstract

During the 2022 global mpox outbreak, gay, bisexual and other men who have sex with men (gbMSM) were disproportionately affected,s however, the true number of cases is likely higher than reported due in part to the stigma associated with mpox. This stigma may have played an even more influential role on health-seeking behaviour in politically conservative regions, such as the Canadian Prairies. The shifting epidemiology may have also led to misdiagnoses during initial months of the outbreaks. Seroprevalence studies can help assess these gaps in surveillance and population-level immunity. To address this, we conducted a cross-sectional seroprevalence study among 275 individuals who identified as potentially eligible to receive the mpox vaccine in the Canadian provinces of Manitoba and Alberta from June 2024 to December 2025 based on provincial vaccination criteria. This eligibility included, but was not exclusively limited to, gbMSM, gender diverse individuals, and sex workers. Dried blood spots were analyzed using the Meso Scale Discovery Orthopoxvirus assay targeting five orthologous mpox and vaccinia virus antigens. In total, 14.5% of individuals self-reported receiving the mpox vaccine and of those without reported Orthopoxvirus vaccination, 5.9% were seroreactive to multiple mpox antigens. These results suggest the potential for undetected mpox circulation within Manitoba and Alberta. While primarily men who have sex with men were eligible for the mpox vaccine, an expansive range of gender and sexual orientation identities were classified as seroreactive, suggesting a misalignment between those who were seroreactive and vaccine eligibility criteria. This emphasizes how broader mpox vaccine eligibility, not restricted by specific gender and sexuality requirements, may better encompass those at risk of infection.

2
Human Infection with Avian Influenza A(H7N7) Virus, Taiwan, 2026

Li, Y.-T.; Lin, Y.-T.; Chen, B.-S.; Kuo, C.-Y.; Huang, H.-Y.; Ko, H.-Y.; Huang, P.-Y.; Smith, G. J.; Lin, Y.-L.; Liu, M.-T.

2026-10-11 infectious diseases 10.64898/2026.10.09.26365013 medRxiv
Top 0.1%
0.9%
Show abstract

Low pathogenic avian influenza A(H7N7) virus detected in a poultry worker in Taiwan, 2026 was related to viruses circulating in Asian wild birds and possessed PB2 E627K, a mammalian adaptation marker. Enhanced surveillance for H7 viruses in poultry and rapid characterization of human cases are essential to assess pandemic potential.

3
Thyroid Dysfunction in Male Patients at Asia Med Laboratory, Herat, Afghanistan July 2021-Jan 2022

Tamkin, N.; Habibi, M.; Leming, M.

2026-09-24 pathology 10.64898/2026.09.19.752850 medRxiv
Top 0.2%
0.5%
Show abstract

Objective: Hyperthyroidism and hypothyroidism related to iodine deficiency are major public health concerns in Afghanistan. This study aimed to assess the frequency of thyroid dysfunction among male patients referred for thyroid testing and its association with age, and to examine monthly trends in thyroid dysfunction at Asia Med Laboratory in Herat, Afghanistan, from July 2021 to January 2022. Methods: A retrospective analysis was conducted on 250 male patients aged 0-69 years. We measured Serum TSH, total T4, and total T3 levels, and thyroid status was classified using age specific reference ranges. In addition, the frequency of thyroid dysfunction was analyzed across age groups with monthly trends of thyroid state. Results: Overall, the euthyroid state consisted of 69.2% of participants, 24.8% with overt hypothyroidism, 3.2% with overt hyperthyroidism, and 2.8% with subclinical hyperthyroidism. Thyroid status differed significantly by age (p = 0.0135), with hypothyroidism increasing in older age groups and reaching its highest proportion among men aged 60-69 years (55.6%). Euthyroidism predominated in patients aged 10-39 years, while hyperthyroidism across age groups remained relatively infrequent. After September 2021, a threefold increase was observed in the total number of male patients referred for thyroid testing. During this period, the proportion of hyperthyroidism increased slightly, whereas hypothyroidism cases declined. Conclusion: In conclusion, hypothyroidism was more frequent with older age. The rise in absolute case numbers after September 2021 likely reflects increased patient referrals, underscoring the need for ongoing monitoring of thyroid function. The study may assist in the early management of thyroid disorders and in reducing their complications.

4
Diagnostic Accuracy of Fine Needle Aspiration Cytology in Thyroid Diseases: Comparison with Histopathological Findings in Hawassa, Ethiopia

Nisro, A. M.; Geremew, T. T.; Tadele, A. K.; Fenta, B. D.; Engida, G. G.; Lukas, F. Y.; Tesgera, T. G.; Alem, A. T.

2026-10-21 pathology 10.64898/2026.10.16.26365726 medRxiv
Top 0.2%
0.5%
Show abstract

Introduction: Thyroid diseases are major health problems and among the most common endocrine disorders worldwide, including in Ethiopia. They are characterized by alterations in hormone secretion, enlargement of the thyroid gland, or both. Fine needle aspiration cytology is an important initial screening tool, and histopathologic examination is essential for the definitive diagnosis of thyroid disease. This study aimed to compare the diagnostic accuracy of fine needle aspiration cytology with histopathology in identifying thyroid diseases. Methods: A cross-sectional study was conducted at three health facilities in Hawassa City, Ethiopia, involving 304 patients who underwent both thyroid fine needle aspiration cytology and histopathologic examination of the same site between 30th October 2024 and 29th October 2025. FNAC results were classified using the Bethesda system, with histopathology as the gold standard. Data were entered into Kobo Toolbox, exported to SPSS version 27, and analyzed using cross-tabulation and chi-square ({chi}{superscript 2}) tests to determine diagnostic accuracy. Result: 304 patient records were included in the study. The fine needle aspiration cytology was determinate/diagnostic in 81.6% of cases. The study revealed the sensitivity and specificity of fine needle aspiration cytology to be 88.2% (CI 77.6-95.1%) and 94.4% (CI 90.6-97.1%), respectively. The false negative and false positive rates in this study were 2.4% and 4.4%, respectively. The positive predictive value was 80.3% (CI 68.7-89.3%), and the negative predictive value was 96.8% (CI 93.8-98.7%). The accuracy of fine needle aspiration cytology in differentiating benign from malignant thyroid lesions was 93.1%. Conclusion: FNAC demonstrated strong agreement with histopathology and remains a reliable, cost-effective first-line diagnostic tool for thyroid disease, particularly in resource-limited settings. Strengthening sample handling, ultrasound guidance, and adherence to Bethesda criteria may further improve diagnostic precision

5
Diagnostic accuracy of image-guided fine needle aspiration cytology in diagnosis of lung tumors

Bhandari, B.; Tiwari, M.; Adhikari, S.; Khanal, A.; Chettri, N. B.; Pandey, S.

2026-08-18 pathology 10.64898/2026.08.17.26360531 medRxiv
Top 0.2%
0.5%
Show abstract

Background: Lung cancer is leading cause of cancer related death globally. It is second most prevalent cancer among women worldwide and ranks third among females in Nepal. Contributing factors are smoking, tobacco use, air pollution, and delayed diagnosis. Image-guided fine needle aspiration cytology (FNAC) is rapid diagnostic technique for evaluating lung lesions. It is minimally invasive procedure with less complications. This study examine histocytologic makeup of lung lesions and link the results. Materials and Methods: This cross-sectional observational study included 65 patients irrespective of age and sex presenting with lung masses at Chitwan Medical College and Teaching Hospital from April 2023 to September 2024. After clinical and radiologic evaluation, all cases underwent image-guided FNAC and biopsy. Only specimens with unequivocal malignant features were classified positive. Histopathology served as diagnostic reference standard. Results: FNAC diagnosed 90.8% as malignant and 9.2% as benign. Biopsy confirmed malignancy in 92.3% of cases. FNAC demonstrated a sensitivity of 98.33%, specificity of 100%, positive predictive value(PPV) of 100%, and negative predictive value (NPV) of 83.33%. Concordance between FNAC and histopathological subtyping was 98.46%. Adenocarcinoma was most common subtype, followed by Squamous cell carcinoma(SCC) and small cell carcinoma. Smoking was most common contributing factor associated with malignancy. Conclusion and implications: Image-guided FNAC is an excellent diagnostic accuracy tool which possess higher level of concordance with biopsy in evaluating lung masses. It should be considered as frontline diagnostic tool, especially in resource limited settings. Keywords: FNAC, Lung cancer, Biopsy, SCC, Adenocarcinoma, Small cell carcinoma, Nepal

6
Serotype distribution and risk factors associated with pneumococcal carriage among children with otitis media in Peninsular Malaysia (2023-2025): A cross-sectional study in the early post-vaccination era

Tang, C. Z.; Ramzi, N. H.; Johari, N. A.; Razali, A.; AshaAri, Z. A.; Kamarudin, N.; Hadi, A. A.; Bakar, S. A.; Nor, K. M.; Chong, C. W.; Lister, A. J. J.; Cleary, D. W.; Clarke, S. C.; Sulaiman, L. H.

2026-07-30 infectious diseases 10.64898/2026.07.28.26359181 medRxiv
Top 0.2%
0.5%
Show abstract

Background Otitis media is a leading cause of childhood morbidity and presents a significant healthcare burden worldwide. Streptococcus pneumoniae is a major aetiological agent of OM, and the introduction of pneumococcal conjugate vaccines into the Malaysian National Immunisation Programme in 2020 would have altered pneumococcal carriage and serotype distribution. This study aimed to determine pneumococcal carriage, serotype distribution, and associated risk factors among children with OM in the early post-PCV era in Peninsular Malaysia. Methods and Findings A total of 360 children with OM were recruited from hospitals on the east and west coasts of Peninsular Malaysia between 2023 and 2025. Nasopharyngeal and middle ear fluid samples were collected for Spn isolation by culture, followed by serotyping using multiplex PCR. Sociodemographic, environmental, and medical history data were analysed for associations with pneumococcal carriage using chi-square, Fishers exact tests, and logistic regression. Pneumococcal carriage was detected in 26.7% of children in either NP or MEF samples, with carriage rates of 25.6% and 1.9% in NP and MEF samples, respectively. The most prevalent serotypes were 23A, 15B/15C, non-typable strains, 19F, and 11A/11D. Daycare attendance (p = 0.012, aOR [95% CI]: 2.177 [1.186 - 3.995] and residence in rural areas (p = 0.019, aOR [95% CI]: 2.476 [1.159 - 5.292] were significantly associated with pneumococcal carriage. The main limitation of the study was the reliance on self-reported questionnaire data, which may have introduced recall bias and reporting errors. Conclusions The predominance of non-vaccine serotypes and non-typable Spn indicates ongoing serotype replacement and the emergence of phase-variant strains in the early post-PCV era. Continued surveillance is essential to monitor these changes and inform the development of next-generation pneumococcal vaccines. This study was registered under clinical trial registration number NCT05429541.

7
2025/26 subclade-specific influenza A and B vaccine effectiveness estimates and discordant laboratory-based indicators of vaccine match or mismatch

Separovic, L.; Kaweski, S. E.; Cox, M. B.; Zhan, Y.; Sabaiduc, S.; Olsha, R.; Hasso, M.; Mather, R. G.; Carazo, S.; Lacroix, C.; Meunier, I.; Salhi, L. N.; Dickinson, J. A.; Zelyas, N.; Jassem, A. N.; Dover, K.; Ranadheera, C.; Gao, R.; Bastien, N.; Skowronski, D. M.

2026-09-12 public and global health 10.64898/2026.09.10.26362769 medRxiv
Top 0.2%
0.5%
Show abstract

Background: The 2025/26 influenza season included A(H3N2) subclade K predominance with A(H1N1)pdm09 co-circulation and subsequent prolonged influenza B activity. The Canadian Sentinel Practitioner Surveillance Network reports vaccine effectiveness (VE) in the context of genetic and antigenic relatedness to circulating viruses. Methods: We estimated VE by test-negative design among outpatients with medically-attended acute respiratory illness between November and April. We characterized case viruses by whole genome sequencing and hemagglutination inhibition assay. Results: Among 2809/9047 (31%) influenza-positive specimens, 82% (2306/2809) were influenza A with 18% (504/2809) influenza B. Of subtyped influenza A, 85% (1848/2169) were A(H3N2). We sequenced 59% (1099/1848) of A(H3N2) viruses, with 87% (956/1099) subclade K, antigenically-mismatched to subclade J.2 vaccine. VE against A(H3N2) and subclade K was 38% (95% confidence interval: 27%-47%) and 33% (19%-45%). We sequenced 69% (222/323) of A(H1N1)pdm09 viruses, virtually all (n=218) clade 5a.2a.1, including subclades D.3.1 (21%; n=47) and D.3.1.1 (77%; n=171), antigenically-matched to subclade D vaccine. VE against A(H1N1)pdm09, subclades D.3.1 and D.3.1.1 was 28% (4%-47%), -21% (-144%-40%) and 44% (14%-64%). We sequenced 82% (413/504) of influenza B viruses, all B/Victoria, including antigenically-mismatched subclade C.3 (18%; n=74) with D197N gain-of-glycosylation, and antigenically-matched subclade C.5 (82%; n=339) relative to subclade C vaccine. VE against influenza B, subclades C.3 and C.5 was 55% (41%-66%), 10% (-60%-49%) and 68% (51%-79%). Conclusions: The 2025/26 influenza vaccine reduced the risk of A(H3N2), A(H1N1)pdm09 and B/Victoria by over one-third, one-quarter and one-half, respectively. Laboratory-based indicators of vaccine match remain uncertain proxies for actual vaccine protection, reinforcing importance of annual epidemiological monitoring of VE.

8
Longitudinal Filovirus Seroreactivity Following Ad26.ZEBOV (Zabdeno) and MVA-BN-Filo (Mvabea) Vaccination in the Democratic Republic of the Congo

Wallace, H. L.; Halbrook, M. L.; Kompany, J. P.; Hoff, N. A.; Merritt, S.; Mukadi, P.; Beya, M.; Kalengi, H.; Tambu, M.; Mossoko, Z.; Kelly, J. D.; Ball, A. H.; To, A.; Wong, T.; Kavunga-Membo, H.; Hensley, L. E.; Lehrer, A. T.; Kindrachuk, J.; Mbala-Kingebeni, P.; Rimoin, A. W.

2026-10-19 infectious diseases 10.64898/2026.10.15.26365698 medRxiv
Top 0.2%
0.4%
Show abstract

Background: Filoviruses, specifically Ebola virus (EBOV), Bundibugyo virus (BDBV), and Marburg virus (MARV), have been the etiologic agents of multiple outbreaks of severe disease in the Democratic Republic of the Congo (DRC). Two EBOV-specific vaccine regimens have been approved for use in outbreak scenarios, including the Ad26.ZEBOV/MVA-BN-Filo (Zabdeno/Mvabea) two-dose vaccine, where the MVA-BN-Filo booster dose contains EBOV, MARV, and Sudan (SUDV) virus glycoproteins (GPs) and the nucleoprotein from Tai Forest virus. While long-term immunogenicity of up to two years has been found in clinical trial settings, limited real-world data exists. Methods: Using a multiplexed immunoassay, samples (n=698 at baseline) collected in Mbandaka, Equateur province, DRC, between September 2023 and October 2024 were assessed for seroreactivity to six filovirus antigens (1 BDBV, 2 EBOV, 2 MARV, and 1 SUDV) at three distinct periods: baseline/pre-vaccination, 6-8 weeks post-first dose (Zabdeno), at booster administration (Mvabea), and one-year post-boost dose. Results: Substantial filovirus seroreactivity was found at baseline, with 48.7% (n=340/698) of individuals being seroreactive to at least one virus antigen. High baseline seroreactivity was found against BDBV GP (31.1%, n=217/698), with lower baseline seroreactivity to EBOV GP (15.5%, n=106/698), comparatively. Overall EBOV GP seroreactivity increased to 66.8% (n=376/563) at one year-post vaccine boost and 57.6% (n=250/434) of participants were seroreactive. Despite the booster dose inclusion of SUDV GP and MARV GP, there were no substantial increases in reactivity against either antigen at subsequent timepoints. Overall filovirus seroreactivity increased at all timepoints for the entire cohort, although filovirus reactivity decreased over the study period for those who were seroreactive at baseline. Findings: These data highlight detection of significantly elevated seoreactivity to EBOV GP following first-dose administration of Ad26.ZEBOV, which remained relatively stable one-year post-booster dose administration. Additionally, this study identifies high levels of baseline seroreactivity to BDBV GP despite no previous documented outbreaks in this region of DRC. These data suggest that vaccination with the Ad26.ZEBOV-MVA-BN-Filo vaccine induces stable seroreactivity against EBOV GP, but not to other filovirus antigens.

9
Applying a multiplex electrochemiluminescence NS1 assay to detect and differentiate Zika and dengue virus exposures in long-term community cohorts in Brazil and Thailand

Nery, N.; Hamins-Puertolas, M.; Bahr, L.; Cruz, J. S.; Lu, J.; Muenker, M. C.; Ticona, J. P. A.; Khosavanna, R.; Fofana, M. O.; Oliveira, D. d.; Buddhari, D.; Hunsawong, T.; Farmer, A.; McGuckin, K. A.; Brooks, J. S.; Iamsirithaworn, S.; Collins, M. H.; Ribeiro, G. S.; Thomas, S. J.; Costa, F.; Reis, M. G.; Cummings, D. A. T.; Anderson, K.; Ko, A. I.; Waickman, A.

2026-09-08 infectious diseases 10.64898/2026.09.04.26362297 medRxiv
Top 0.2%
0.4%
Show abstract

Background: Distinguishing Zika virus (ZIKV) from dengue virus (DENV) infection remains a major diagnostic challenge in co-endemic regions due to antigenic cross-reactivity. We evaluated a multiplex electrochemiluminescence Meso Scale Discovery System (MSD) NS1 assay to define ZIKV infection with high specificity across diverse immune backgrounds. Methods: We analyzed longitudinal samples from PCR-confirmed ZIKV and DENV infections across multiple cohorts, assessed correlations between MSD NS1 signal intensities and PRNT50 titres, and performed ROC analyses to derive seroconversion thresholds. We then applied these criteria to identify ZIKV seroconversions in Brazil (2015-2024) and Thailand (2015-2025). Findings: ZIKV infections produced sustained NS1 responses, whereas primary DENV infections showed minimal ZIKV cross-reactivity and secondary DENV infections exhibited only transient, low-level increases. MSD NS1 signal intensities correlated with PRNT50 titres for ZIKV and all four DENV serotypes (rho = 0.54-0.84). ROC analyses identified a fold-change of at least 10.96 as the optimal ZIKV seroconversion cutoff, with an AUC of 100% among DENV-naive and 90.7% among DENV-exposed participants. Adding a second criterion - ZIKV/DENV fold-change ratio > 1 - further increased specificity. Application of this dual-threshold framework revealed high ZIKV incidence during the 2015-2016 epidemic in Brazil and very low incidence in the post-epidemic period. In the Thailand cohort, synchronous seroconversion among household members suggested potential intra-household transmission. Interpretation: The MSD NS1 multiplex assay provides a scalable, quantitative, and highly specific approach for identifying ZIKV infection and estimating seroincidence in co-endemic settings. The dual-threshold framework (fold-change of at least 10.96 and ZIKV/DENV ratio > 1) enhances diagnostic precision, offering a robust tool for surveillance and transmission studies in flavivirus-endemic regions.

10
Antibody profiles across H5N1 and previously circulating viruses are highly dynamic and age- and imprint- independent

Beukema, M.; Vermeulen, E.; de Vries-Idema, J.; Huckriede, A.; Joshi, M.

2026-08-31 infectious diseases 10.64898/2026.08.26.26361396 medRxiv
Top 0.3%
0.4%
Show abstract

The increasing incidence of H5N1 influenza virus transmission from animal species to humans has heightened concerns about an imminent H5N1 pandemic. Prior studies using recombinant hemagglutinin and neuraminidase proteins have reported age-dependent cross-reactivity to H5N1, attributed to immune imprinting from an individual's first influenza virus exposure. However, whether this pattern holds when using whole inactivated virus (WIV), capturing antibodies against diverse viral proteins, and is stable over time remains unknown. We therefore aimed to determine whether H5N1 cross-reactivity of pre-existing antibodies to whole virus follows an age-dependent or imprinting-specific pattern, and whether this pattern is stable over a five-year period. To this end, we measured serum antibody levels in adolescents, adults and seniors by ELISA using whole inactivated H5N1 virus as antigen rather than purified proteins. Detectable, albeit generally low, levels of H5N1-reactive antibodies were present in most individuals, irrespective of age. Comparison of antibody levels against H5N1 with those to five historical influenza virus strains revealed a consistent positive correlation between H5N1-reactive antibodies and responses to the H1N1pdm09 strain A/California/7/2009 (CA), across all age groups. Using unbiased clustering of antibody titers against H5N1, CA, and the H3N2 strain A/Perth/16/2009 (PE), we identified seven distinct age-transcending antibody profiles. These profiles covered individuals with varying titers to all three included viruses but also identified individuals with high anti-CA levels, yet low anti-H5N1 levels and vice versa. Moreover, despite stable antibody levels over a five-year interval in the study population, individual antibody levels and profiles fluctuated considerably over this period. Taken together, our results confirm the presence of H5N1-reactive antibodies in human sera and their association with previously circulating strains. However, they also caution against inferring antibody levels against a new strain based solely on responses to antigenically related strains and highlight the limitations of extrapolating immune status from single timepoint measurements.

11
First report on Tropilaelaps mercedesae presence in Turkiye and insight into potential westward invasion corridors

Ozkirim, A.; Uzunov, A.; Costa, C.; Kandemir, I.

2026-09-22 pathology 10.64898/2026.09.15.751928 medRxiv
Top 0.3%
0.3%
Show abstract

The honey bee ectoparasitic mite Tropilaelaps mercedesae is an emerging threat to Western beekeeping, as it is expanding its range from native Asia. In this study, the first record of the presence of Tropilaelaps mercedesae in Turkiye, in the Artvin province, in the north-east of the country is documented. Following reports of weakening colonies, eight apiaries were inspected using the rapid brood decapping method. All apiaries were found positive, and infestation was detected in 22 of 24 examined colonies. Mite samples were analysed with morphometry and barcoding and were confirmed as T. mercedesae. In the paper, we discuss the impact of imports and migration practices on the mites occurrence in Turkiye. In addition, we forecast the potential corridors and means of further invasion and address the implications for European and global apiculture.

12
Livestock production intensity and mucosal IgA and IgG responses to H5N1 highly pathogenic avian influenza A virus, North Carolina, 2021-2022

Pisanic, N.; Kurowski, K. M.; Carter, T.; Salmeron, B.; Spicer, K.; Krucynski, K. L.; Gigot, C. M.; Schmidt, L.; Aubourg, M. A.; Hall, D. J.; Hall, D. J.; Mitchell, L.; Johnson, L.; George, M.; Rule, A. M.; Moss, W. J.; Davis, M. F.; Pekosz, A.; Gronvall, G. K.; Heaney, C. D.

2026-08-10 infectious diseases 10.64898/2026.08.06.26359901 medRxiv
Top 0.3%
0.3%
Show abstract

Background. Direct livestock exposure is a risk factor for zoonotic influenza, including H5N1 highly pathogenic avian influenza (HPAI) A virus. But whether living in regions of high poultry and swine production intensity (PPI, SPI) increases risk of exposure to zoonotic influenza viruses independent of occupational livestock contact remains unclear. Objectives. To determine whether livestock workers and community members with no occupational livestock exposure in North Carolina, where poultry and swine production are increasingly co-located, are at higher risk of exposure to zoonotic influenza. Methods. Saliva samples from industrial livestock operation worker (ILO-W), ILO neighbor (ILO-N) and metropolitan area (Metro) households were analyzed for mucosal influenza A (H5N1, H1N1, and H3N2) hemagglutinin (HA) IgA and IgG antibodies to determine associations of PPI, SPI, exposure group, and detection of a swine-specific fecal contamination marker (Pig-2-Bac DNA) with influenza A antibody levels. Results. Residing in the highest PPI and SPI tertile was associated with significantly higher mucosal H5 and H1 HA IgA levels, including among residents without occupational livestock exposure. Households with occupational poultry or swine contact had significantly higher H5 IgA and IgG and H1 IgA levels compared to Metro households. In regression models accounting for clustering at the participant level, log10 anti-H5 HA mucosal IgA increased 0.16 (95% CI: 0.06, 0.27, p<0.005) and 0.10 (95% CI: 0.03, 0.17, p<0.005), per log10 increase in PPI and SPI, respectively, and 0.16 (95% CI: 0.03, 0.19, p<0.02) when Pig-2-Bac DNA was detected on household surfaces. Conclusions. Mucosal H5 HA IgA and IgG and H1 HA IgA were consistently elevated across different metrics of livestock exposure intensity, including residential exposure, occupational contact within a household, and a molecular marker of household swine fecal contamination in a state with intensive poultry and swine production.

13
Geographic distribution of Adult Salmon Enteritis (ASE), Enterocytozoon schreckii, and Ceratonova shasta in Chinook Salmon Oncorhynchus tshawytscha (Walbaum, 1792) in Oregon and Washington state and expanded histopathologic description of ASE

Polley, T.; Bermudez Pose, R.; Loehr, C.; Hickey, N.; Strickland, S.; Schuster, C.; Kent, M.

2026-09-20 pathology 10.64898/2026.09.14.751509 medRxiv
Top 0.3%
0.3%
Show abstract

Adult salmon enteritis (ASE) is a severe intestinal disease affecting spring Chinook Salmon (Oncorhynchus tshawytscha) in the Pacific Northwest. ASE is strongly associated with pre-spawn mortality (PSM), a critical concern for endangered populations and continued Chinook Salmon management. This study characterizes the geographic distribution of ASE across Oregon and Washington watersheds, examines its association with two common parasites (Ceratonova shasta and Enterocytozoon schreckii), and provides detailed histopathological characterization of the disease. We examined intestinal tissues from 259 adult spring Chinook Salmon collected from multiple hatcheries across the Columbia River Basin and Puget Sound between 2022 and 2025 using routine histopathology, specific histochemical stains, and immunohistochemistry. ASE was highly prevalent in all Columbia Basin populations, with chronic ulcerative and necrotizing enteritis, but was absent in Puget Sound populations. C. shasta prevalence was high in most Columbia Basin locations (10-100%), while E. schreckii prevalence was more variable (0-67%). Consistent histopathological findings of ASE included [&ge;] 10% mucosal ulceration, mixed inflammation expanding the lamina propria and extending into surrounding intestinal layers, and dissolution of the stratum granulosum. In chronic ASE lesions, we further characterized granulation tissue formation. Cold water holding of spawning adults appears to slow disease progression and reduce PSM without preventing ASE development. These findings demonstrate that ASE is a geographically restricted disease of the Columbia Basin that may have associations with diverse environmental exposures including water temperature and pathogens.

14
Clinical Phenotypes of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection: A Longitudinal Cohort Study from Karachi, Pakistan

Khanum, I.; Ahmed, K.; Munir, T.; Zia, H.; Saif, W.; Sadia, H.; Mahmood, S. F.; Nasir, N.; Ghias, K.; Rabinowitz, P.; Van Voorhis, W.; Iqbal, N. T. T.

2026-09-08 infectious diseases 10.64898/2026.09.04.26361413 medRxiv
Top 0.3%
0.3%
Show abstract

Post Acute Sequelae of SARS CoV 2 infection, or PASC, is an emerging public health concern. Longitudinal data from South Asia remain limited and the burden of persistent symptoms in Pakistan is not well characterized. This study examined the long term clinical course of PASC and its relationship with fecal viral shedding and serotonin levels over a 12 month follow up period. We conducted a prospective longitudinal study of individuals with PASC. Participants underwent serial assessments of clinical symptoms, stool SARS CoV 2 RNA detection, and serum serotonin measurements. A symptom score was developed using 22 symptoms reported by more than 30 percent of participants. Participants were predominantly female with 60 percent female participation and a mean age of 42.1 years. Overall, 66 percent were overweight or obese and 23 percent reported multiple SARS CoV 2 reinfections. Symptom burden decreased significantly at 9 months and 12 months compared with baseline. Despite overall improvement, several symptoms persisted. Myalgia remained common, increasing slightly from 60 percent at baseline to 63 percent at 12 months. Musculoskeletal symptoms remained stable at approximately 60 percent. Neurocognitive symptoms declined from 40 percent to 31.3 percent, whereas psychological symptoms increased slightly from 40 percent to 45.8 percent. Fecal viral shedding was detected in 50 percent of participants and demonstrated intermittent or persistent patterns. Significant associations between fecal shedding and symptoms emerged at 6 months, particularly breathlessness, fatigue, weakness, and joint pain. Serotonin levels were comparable to those reported during acute COVID 19 infection. PASC symptoms including myalgia, joint pain, weakness, and fatigue persisted for up to one year after infection. The association between ongoing fecal viral shedding and persistent symptoms suggests that viral persistence and sustained physiological disturbances may contribute to Long COVID pathogenesis in a subset of individuals.

15
Genitourinary Brucellosis in an Endemic Region: Clinical Spectrum, Diagnostic Pitfalls and Treatment Outcomes of a 13-Year Retrospective Cohort

Savas, L.; Pekok, A. U.; Pekok, B. S.; Eser, Z. S.

2026-09-24 infectious diseases 10.64898/2026.09.22.26363646 medRxiv
Top 0.3%
0.3%
Show abstract

Aim: Brucellosis remains endemic throughout the Mediterranean basin, the Middle East and Central Asia. Genitourinary involvement is an uncommon but clinically consequential focal complication that closely mimics urological emergencies and may precipitate unnecessary surgery. Contemporary data describing its frequency, laboratory signature and treatment outcomes in endemic settings remain limited. Material-Methods: We retrospectively screened all adults ([&ge;]18 years) with confirmed brucellosis managed at a tertiary infectious diseases unit between January 2008 and December 2020. Genitourinary involvement was defined as epididymo-orchitis, orchitis, epididymitis and/or brucellar pyelonephritis. Clinical, laboratory, ultrasonographic, therapeutic and outcome variables were abstracted using a standardised form. Proportions are reported with Wilson score 95% confidence intervals (CI). Reporting followed the STROBE statement. Result: Genitourinary involvement was identified in 18 of 125 patients with brucellosis (14.4%; 95% CI 9.3-21.6); 16 (88.9%) were men and the mean age was 35.2 years (range 22-62). Scrotal disease dominated the male presentation: epididymo-orchitis in 10 of 16 men (62.5%; 95% CI 38.6-81.5), orchitis in 4 (25.0%) and epididymitis in 2 (12.5%). Both women presented with pyelonephritis, one of whom developed a tubo-ovarian abscess requiring drainage. Constitutional features were near-universal (fatigue 100%, night sweats 88.9%, fever 77.8%). Leukocyte counts remained within the reference interval in every patient (mean 5,680/mm3), whereas erythrocyte sedimentation rate (mean 32 mm/h) and C-reactive protein (mean 24.2 mg/L) were only mildly to moderately raised. The Coombs anti-Brucella test was positive in 18 of 18 patients (100%) and the standard agglutination test in 17 of 18 (94.4%), whereas blood culture yielded Brucella melitensis in only 1 of 18 (5.6%). Concomitant extragenitourinary focal disease was present in 8 patients. All patients received doxycycline plus rifampicin; none required modification of the regimen or orchiectomy, and no treatment failure occurred (0 of 18; 95% CI 0-17.6). Median follow-up was 12 weeks (range 6-52) and no relapse was documented within this interval. Conclusions: In endemic regions, genitourinary brucellosis should be suspected in any patient with acute scrotal or flank symptoms accompanied by constitutional complaints, even when the leukocyte count is normal and acute-phase reactants are only marginally elevated. Coombs anti-Brucella serology rather than blood culture is the diagnostic cornerstone, and prompt doxycycline-rifampicin therapy averts surgical intervention.

16
Types, Subtypes and Positivity Rates of Seasonal Influenza in Uganda, 2019-2023

Nankya, M. A.; Owor, N.; Kayiwa, J. T.; Lutwama, J. J.; Gidudu, S.; Bahizi, G.; Ario, A. R.

2026-09-01 infectious diseases 10.64898/2026.08.29.26361662 medRxiv
Top 0.3%
0.3%
Show abstract

Background: Seasonal influenza, commonly known as flu, is an acute respiratory, highly contagious illness caused by influenza viruses. A clear understanding of influenza seasonality is crucial for guiding prevention and treatment strategies, including decisions on vaccination timing to prevent outbreaks. While well documented in temperate regions, data on influenza epidemiology in tropical areas, particularly sub-Saharan Africa, remain limited. We described the types, subtypes and positivity rate of seasonal influenza in Uganda during 2019-2023. Methods: We abstracted data from the National Influenza database on positive seasonal influenza cases confirmed by Polymerase Chain Reaction. The cases were disaggregated by age group, sex, region, month and year of reporting. Using Microsoft excel, we calculated the influenza positivity rate and disaggregated it by strain, sex, age, region and time. Test positivity rate was computed as the number of positive cases as a percentage of the total samples tested. Results: Among 17,957 individuals tested, the overall positivity rate for seasonal influenza was 5% (936 cases). Positivity was higher among males compared to females (7% vs. 4%), with children aged 5-9 years having the highest positivity rate (16%), while individuals aged 50-54 years had the lowest (1%). The median positivity rate was 4%, with a range of 1-16%. Regionally, the central region reported a positivity rate of 5%, with rates across all regions ranging from 5% to 8%. Over time, there was a gradual decline in positivity rates, decreasing from 16.5% in 2019 to 5.3% in 2023. Seasonal influenza exhibited bimodal peaks, with the primary peak occurring between March and May and a secondary peak from October to December. Influenza A was the predominant strain, accounting for 70% of seasonal influenza cases (669/936). Among the Influenza A subtypes, H3N2 was most common, representing 63% of cases (425/669). Conclusions: The declining seasonal influenza positivity rates from 2019 to 2023 and the predominance of Influenza A and H3N2 highlight the need for sustained surveillance in Uganda. Given Influenza A's high genetic variability and potential for novel strain emergence, monitoring circulating strains, informing vaccine development, and implementing targeted interventions for high-risk groups and regions are critical to controlling and preventing outbreaks.

17
Clinical features of COVID-19 patients hospitalized at the Tashkent State Medical University and risk factors for intensive care unit admission: a cross-sectional study from Uzbekistan, Central Asia

Rakhimov, B.; Choi, J.; Kim, K.; Tuychiev, L.; Shadmanov, A.; Mamatkulov, B.

2026-08-31 infectious diseases 10.64898/2026.08.28.26361631 medRxiv
Top 0.3%
0.3%
Show abstract

Background. The clinical course of coronavirus disease 2019 (COVID-19), and the ability to anticipate which patients will require intensive care, were poorly characterized in Central Asia during the first pandemic wave. We aimed to describe the clinical features of hospitalized COVID-19 patients at the Tashkent State Medical University, Uzbekistan, and to identify risk factors for intensive care unit (ICU) admission. Methods. In this single-centre cross-sectional study, we reviewed the records of 2500 consecutive patients hospitalized between 11 April and 8 August 2020. Patients were grouped as asymptomatic or symptomatic, and symptomatic patients were compared by ICU versus non-ICU status. Groups were compared with chi-square or Fisher's exact and Mann-Whitney U tests. Univariable and multivariable logistic regression identified risk factors for ICU admission. Results. Of 2500 patients (median age 36 years; 60.9% male), 989 (39.6%) were asymptomatic and 1511 (60.4%) symptomatic. In total, 129 (5.2%) were admitted to the ICU and 38 (1.5%) died. ICU patients were older (median 56 vs 40.5 years) and more often had bilateral pneumonia, oxygen desaturation and cardiometabolic comorbidity. In the multivariable model (AUC 0.82), the independent predictors of ICU admission were ischemic heart disease (aOR 4.20), shortness of breath (aOR 3.22), hypertensive heart disease (aOR 2.93) and male sex (aOR 2.00). Conclusions. Older age, cardiometabolic comorbidity and respiratory compromise identified patients at high ICU risk. As one of the first clinical COVID-19 descriptions from Uzbekistan, these data provide a baseline for preparedness in Central Asia.

18
Obesity in children is associated with increased dengue virus binding, but not neutralizing, antibody responses following primary infection

Mercado-Hernandez, R.; Bos, S.; Kuan, G.; Balmaseda, A.; Harris, E.

2026-08-17 infectious diseases 10.64898/2026.08.14.26360483 medRxiv
Top 0.3%
0.3%
Show abstract

Background. Obesity has been associated with higher risk of dengue virus (DENV) infection and disease, yet its influence on antibody responses to DENV remains undefined. Methods. We evaluated whether nutritional status -- based on BMI z-score (BMIz) -- or blood markers of body fat -- leptin and adiponectin --are associated with binding and/or neutralizing antibody responses to DENV in 85 children in the Nicaraguan Pediatric Dengue Cohort Study who experienced a primary DENV infection in 2019. Associations were estimated using linear models adjusting for age, sex, and DENV infection outcome. Results. Compared to children with normal weight, those with obesity had higher quantities of DENV binding antibodies (fold-change [FC] 1.89, 95% confidence interval [CI] 1.02, 3.48) but no difference in neutralizing antibodies. Likewise, leptin concentration was associated with higher quantities of binding antibodies (FC 1.22, 95%CI 1.09, 1.37), while adiponectin was associated with lower quantities (FC 0.79, 95%CI 0.67, 0.94), and neither was associated with neutralizing antibodies. Lower neutralizing efficiency (neutralizing/binding antibodies) was observed in children with obesity (FC 0.67, 95%CI 0.48, 0.93). Conclusions. Our results indicate that obesity is associated with higher antibody quantity (binding) but not higher quality (neutralization) post-primary DENV infection -- implying that antibodies generated by children with obesity have lower neutralization efficiency, requiring greater quantities to reach similar levels of neutralization than children with normal weight. Further, the agreement among the three models using distinct proxies of body fat -- BMIz, leptin, and adiponectin -- demonstrates that adipokines are useful in supplementing BMIz analysis or as independent predictors of immune responses.

19
Implementation of a Multimodal Diagnostic Algorithm for Blood Culture-Negative Infective Endocarditis at the Argentine National Reference Laboratory: A Prospective Study

Armitano, R.; Martinez, G.; Prieto, M.

2026-08-10 infectious diseases 10.64898/2026.08.06.26359889 medRxiv
Top 0.3%
0.3%
Show abstract

Background: Blood culture-negative infective endocarditis (BCNIE) poses a significant diagnostic challenge. This study evaluated a multimodal diagnostic algorithm combining serological and molecular methods at the Argentine National Reference Laboratory. Methods: A prospective analysis was conducted on 53 consecutive patients with suspected BCNIE referred between January 2019 and December 2024. The diagnostic workflow included indirect immunofluorescence for Bartonella spp. and Coxiella burnetii, species-specific PCR for Bartonella spp. and Tropheryma whipplei, and broad-range 16S rRNA PCR with Sanger sequencing on available blood and valvular tissue specimens. Results: An etiological diagnosis was established in 17 of 53 patients (32.1%). Bartonella spp. was the predominant pathogen (47.1%; 8/17), followed by T. whipplei (35.3%; 6/17) and Streptococcus spp. (17.6%; 3/17). All Bartonella cases were initially detected via serology, with molecular confirmation achieved exclusively through valvular tissue analysis. Conclusions: Implementing a standardized multimodal diagnostic algorithm significantly enhances etiological yields in BCNIE. The findings emphasize the complementary value of frontline serology and targeted molecular testing, highlighting that simultaneous submission of serum, blood, and valvular tissue is essential for optimal diagnosis.

20
Hepatitis E Virus Prevalence and Associated Risk Factors in Pregnant Women Attending Antenatal Consultations Niger Republic, 2025

Hassane, F.; Lagare, A.; Yacouba, A.; Ousmane, H.; Issa, M.; Magagi, L. H.; Aoula, B.; Kaka, B. K.; Diallo, O.; Djedenam, M.; DOUTCHI, M.; Mamadou, S.

2026-10-07 infectious diseases 10.64898/2026.10.05.26364823 medRxiv
Top 0.4%
0.2%
Show abstract

Background: Hepatitis E virus (HEV) is highly endemic in several African countries with high mortality rate among pregnant women. The prevalence of HEV in Niger among pregnant women is unknown. We hereby aim to report the prevalence and risk factors of HEV among pregnant women in Niamey, Niger. Methods: Blood samples were collected from pregnant women attending antenatal consultation in three selected Health centers in Niamey. Data were collected for socio demographic characteristics using a structured questionnaire. Samples were tested using ELISA and qRT-PCR for anti- HEV IgM and RNA detection respectively. HEV associated risk factors were determined using multivariate logistic regression models. Results: A total of 491 pregnant women were enrolled with mean age of 26.5 years. The prevalence of anti-HEV IgM antibodies was 17.1%, while HEV RNA was detected in 3.46% of participants, indicating recent and active HEV infection. Anti-HEV IgM seropositivity was more frequent among women aged 26-30 years and those in the third trimester of pregnancy. Gravidity was significantly associated with HEV RNA positivity (p = 0.032). In multivariable analysis, the use of well water was independently associated with HEV infection (aOR = 75.70; 95% CI: 1.23-4643.20; p = 0.039). Conclusion: In view of the high seroprevalence of HEV among pregnant women, preventive measures including hygiene sensitization should be prioritized. Further studies should be conducted to assess the real impact of HEV infection on maternal and fetal health.